{"id":24823,"date":"2023-08-29T18:40:17","date_gmt":"2023-08-29T16:40:17","guid":{"rendered":"https:\/\/www.healthitalia.it\/gbc-ag-investment-research-broker-tedesco-leader-nel-mercato-delle-piccole-e-medie-imprese-quotate-inizia-la-copertura-del-titolo-health-italia-con-raccomandazione-buy-e-target-price-a-e-400\/"},"modified":"2023-08-30T09:51:40","modified_gmt":"2023-08-30T07:51:40","slug":"gbc-ag-investment-research","status":"publish","type":"post","link":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/","title":{"rendered":"GBC AG &#8211; Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00"},"content":{"rendered":"<p><em>Formello (RM), 29 August 2023<\/em> \u2013 <strong>Health Italia S.p.A (EGM: HI)<\/strong>, tra i principali attori nel mercato italiano della sanit\u00e0 integrativa e delle soluzioni per il welfare e benessere di famiglie e dipendenti di aziende, comunica che, in data odierna, il broker tedesco <strong>GBC AG \u2013 Investment Research<\/strong> ha pubblicato la \u201cricerca di inizio copertura del titolo Health Italia\u201d, con raccomandazione <strong>BUY<\/strong> e un <strong>Target Price (TP) di \u20ac 4,00 per azione.<\/strong><\/p>\n<p>La valutazione da parte di GBC riflette i punti di forza chiave dell\u2019azienda come, ad esempio, la copertura su scala nazionale, che consente l\u2019accesso ad un\u2019ampia base di clienti e apre prospettive di espansione verso nuovi mercati potenziali ed inoltre, l\u2019offerta integrata del Gruppo, lungo l\u2019intera catena del valore che migliora la competitivit\u00e0. Il solido posizionamento di Health Italia, in un settore in crescita costante, fornisce una base stabile per un successo sostenibile nel tempo.<\/p>\n<p><strong>GBC AG<\/strong> \u00e8 un broker tedesco, attivo dal 1999, leader in Germania nel segmento di mercato composto da piccole e medie imprese quotate, con una Market Cap compresa tra 10 e 500 milioni di euro. GBC AG ha un portafoglio clienti composto da oltre 100 emittenti, e pu\u00f2 contare su un ampio network di Investitori Istituzionali, Family office, Private Equity, Fondi Pensione, nonch\u00e9 Wealth Management.<\/p>\n<p>Livia Foglia, <strong>Amministratore Delegato di Health Italia<\/strong>, ha cos\u00ec commentato: <em>\u201cCon l\u2019inizio di questa seconda copertura sul titolo Health Italia, vogliamo dare al nostro azionariato anche un respiro internazionale, fiduciosi di poter interagire con un\u2019ampia platea di investitori istituzionali, family office, wealth Management parte del vasto network internazionale del Gruppo tedesco CGB. Siamo ottimisti nel pensare che la ricerca di GCB \u2013 AG Investment Research coadiuvata da quella di Banca Profilo, diffusa il 4 agosto scorso, possano dare un nuovo impulso al corso dell\u2019azione Health italia\u201d.<\/em><\/p>\n<p><a href=\"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/CS-HI-inizio-copertura-GBC-AG-Clean.pdf\" rel=\"noopener\" target=\"_blank\">Read the full press release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Formello (RM), 29 August 2023 \u2013 Health Italia S.p.A (EGM: HI), tra i principali attori nel mercato italiano della sanit\u00e0 integrativa e delle soluzioni per il<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":6,"featured_media":24813,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[156],"tags":[],"class_list":["post-24823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GBC AG - Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00 - Health Italia S.p.A.<\/title>\n<meta name=\"description\" content=\"Health Italia operates in the market for the promotion of integrative and substitute healthcare solutions and provides administrative, liquidative, IT and consultancy services.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GBC AG - Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00 - Health Italia S.p.A.\" \/>\n<meta property=\"og:description\" content=\"Health Italia operates in the market for the promotion of integrative and substitute healthcare solutions and provides administrative, liquidative, IT and consultancy services.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Health Italia S.p.A.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HealthItaliaSpA\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-29T16:40:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-30T07:51:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Andrea Varvara\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HealthItalia\" \/>\n<meta name=\"twitter:site\" content=\"@HealthItalia\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Andrea Varvara\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/\"},\"author\":{\"name\":\"Andrea Varvara\",\"@id\":\"https:\/\/www.healthitalia.it\/es\/#\/schema\/person\/0584d894f76df1e0d8c8a0fa1d066d3b\"},\"headline\":\"GBC AG &#8211; Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00\",\"datePublished\":\"2023-08-29T16:40:17+00:00\",\"dateModified\":\"2023-08-30T07:51:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/\"},\"wordCount\":332,\"publisher\":{\"@id\":\"https:\/\/www.healthitalia.it\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/\",\"url\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/\",\"name\":\"GBC AG - Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00 - Health Italia S.p.A.\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthitalia.it\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg\",\"datePublished\":\"2023-08-29T16:40:17+00:00\",\"dateModified\":\"2023-08-30T07:51:40+00:00\",\"description\":\"Health Italia operates in the market for the promotion of integrative and substitute healthcare solutions and provides administrative, liquidative, IT and consultancy services.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#primaryimage\",\"url\":\"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg\",\"contentUrl\":\"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg\",\"width\":1000,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthitalia.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GBC AG &#8211; Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthitalia.it\/es\/#website\",\"url\":\"https:\/\/www.healthitalia.it\/es\/\",\"name\":\"Health Italia S.p.A.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.healthitalia.it\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthitalia.it\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.healthitalia.it\/es\/#organization\",\"name\":\"Health Italia S.p.A.\",\"url\":\"https:\/\/www.healthitalia.it\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.healthitalia.it\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2016\/11\/Health-Italia.png\",\"contentUrl\":\"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2016\/11\/Health-Italia.png\",\"width\":1089,\"height\":1359,\"caption\":\"Health Italia S.p.A.\"},\"image\":{\"@id\":\"https:\/\/www.healthitalia.it\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/HealthItaliaSpA\/\",\"https:\/\/x.com\/HealthItalia\",\"https:\/\/www.linkedin.com\/company\/health-italia\",\"https:\/\/www.youtube.com\/channel\/UCEyLO9k0oyfSYVTYcZZ5tNw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthitalia.it\/es\/#\/schema\/person\/0584d894f76df1e0d8c8a0fa1d066d3b\",\"name\":\"Andrea Varvara\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.healthitalia.it\/es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f7888e45361c6e46ec68631d65971575d62ef3edfd46e3bb0928b8745212265?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f7888e45361c6e46ec68631d65971575d62ef3edfd46e3bb0928b8745212265?s=96&d=mm&r=g\",\"caption\":\"Andrea Varvara\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GBC AG - Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00 - Health Italia S.p.A.","description":"Health Italia operates in the market for the promotion of integrative and substitute healthcare solutions and provides administrative, liquidative, IT and consultancy services.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/","og_locale":"en_US","og_type":"article","og_title":"GBC AG - Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00 - Health Italia S.p.A.","og_description":"Health Italia operates in the market for the promotion of integrative and substitute healthcare solutions and provides administrative, liquidative, IT and consultancy services.","og_url":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/","og_site_name":"Health Italia S.p.A.","article_publisher":"https:\/\/www.facebook.com\/HealthItaliaSpA\/","article_published_time":"2023-08-29T16:40:17+00:00","article_modified_time":"2023-08-30T07:51:40+00:00","og_image":[{"width":1000,"height":700,"url":"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg","type":"image\/jpeg"}],"author":"Andrea Varvara","twitter_card":"summary_large_image","twitter_creator":"@HealthItalia","twitter_site":"@HealthItalia","twitter_misc":{"Written by":"Andrea Varvara","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#article","isPartOf":{"@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/"},"author":{"name":"Andrea Varvara","@id":"https:\/\/www.healthitalia.it\/es\/#\/schema\/person\/0584d894f76df1e0d8c8a0fa1d066d3b"},"headline":"GBC AG &#8211; Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00","datePublished":"2023-08-29T16:40:17+00:00","dateModified":"2023-08-30T07:51:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/"},"wordCount":332,"publisher":{"@id":"https:\/\/www.healthitalia.it\/es\/#organization"},"image":{"@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/","url":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/","name":"GBC AG - Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00 - Health Italia S.p.A.","isPartOf":{"@id":"https:\/\/www.healthitalia.it\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#primaryimage"},"image":{"@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg","datePublished":"2023-08-29T16:40:17+00:00","dateModified":"2023-08-30T07:51:40+00:00","description":"Health Italia operates in the market for the promotion of integrative and substitute healthcare solutions and provides administrative, liquidative, IT and consultancy services.","breadcrumb":{"@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#primaryimage","url":"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg","contentUrl":"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2023\/08\/investimenti-finanziari.jpg","width":1000,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthitalia.it\/en\/gbc-ag-investment-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthitalia.it\/en\/"},{"@type":"ListItem","position":2,"name":"GBC AG &#8211; Investment Research, leading German broker in the market of small and medium-sized listed companies, begins hedging the Health Italia share with a BUY recommendation and a Target Price of \u20ac4.00"}]},{"@type":"WebSite","@id":"https:\/\/www.healthitalia.it\/es\/#website","url":"https:\/\/www.healthitalia.it\/es\/","name":"Health Italia S.p.A.","description":"","publisher":{"@id":"https:\/\/www.healthitalia.it\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthitalia.it\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.healthitalia.it\/es\/#organization","name":"Health Italia S.p.A.","url":"https:\/\/www.healthitalia.it\/es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.healthitalia.it\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2016\/11\/Health-Italia.png","contentUrl":"https:\/\/www.healthitalia.it\/wp-content\/uploads\/2016\/11\/Health-Italia.png","width":1089,"height":1359,"caption":"Health Italia S.p.A."},"image":{"@id":"https:\/\/www.healthitalia.it\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HealthItaliaSpA\/","https:\/\/x.com\/HealthItalia","https:\/\/www.linkedin.com\/company\/health-italia","https:\/\/www.youtube.com\/channel\/UCEyLO9k0oyfSYVTYcZZ5tNw"]},{"@type":"Person","@id":"https:\/\/www.healthitalia.it\/es\/#\/schema\/person\/0584d894f76df1e0d8c8a0fa1d066d3b","name":"Andrea Varvara","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.healthitalia.it\/es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7f7888e45361c6e46ec68631d65971575d62ef3edfd46e3bb0928b8745212265?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f7888e45361c6e46ec68631d65971575d62ef3edfd46e3bb0928b8745212265?s=96&d=mm&r=g","caption":"Andrea Varvara"}}]}},"_links":{"self":[{"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/posts\/24823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/comments?post=24823"}],"version-history":[{"count":1,"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/posts\/24823\/revisions"}],"predecessor-version":[{"id":24829,"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/posts\/24823\/revisions\/24829"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/media\/24813"}],"wp:attachment":[{"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/media?parent=24823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/categories?post=24823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthitalia.it\/en\/wp-json\/wp\/v2\/tags?post=24823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}